LPAR6 and urinary bladder carcinoma: Additionally, high LPAR6 expression significantly impacts disease-specific survival (DSS) in bladder cancer (Supplementary Figure S1A) and OS (Supplementary Figure S1B,M), relapse-free survival (RFS) (Supplementary Figure S1C), DSS (Supplementary Figure S1D,H), distant metastasis-free survival (DMFS) (Supplementary Figure S1N) in breast cancer.